
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.27%
+11.04%
+4.05%
+4.40%
-17.14%
Most Trending
-0.27%
+11.04%
+4.05%
+4.40%
-17.14%
09 Feb 2026NASDAQ opened on a soft note but quickly reversed higher, climbing about 1% as risk appetite improved through the session. The S&P 500 added roughly 0.6% while the Dow lagged with modest gains. The shift from early weakness to broad-based buying reflects a market still willing to lean into growth, even as macro uncertainty looms.
$LLY Eli Lilly is expanding deeper into RNA therapeutics with its $2.4 billion acquisition of Orna Therapeutics. The deal, structured with upfront cash and milestone payments, strengthens Lilly pipeline in oncology and autoimmune diseases. For investors, this signals continued capital deployment into next-generation platforms that could drive long-duration revenue growth beyond its current blockbuster portfolio.
$NVDA Nvidia continues to build on prior gains as markets price in stronger GPU demand tied to Amazon aggressive AI infrastructure spending. The stock remains a core proxy for AI capital expenditure trends, and its resilience reinforces the narrative that hyperscaler investment cycles are still in expansion mode.
$ORCL Oracle moves higher following an analyst upgrade highlighting renewed upside in its partnership with OpenAI. Structural changes and fresh funding at OpenAI reduce counterparty risk and improve visibility around large-scale cloud commitments. For traders, Oracle positioning at the intersection of enterprise cloud and AI infrastructure keeps it firmly in focus.
$NVO Novo Nordisk rallies after regulatory pressure pushed Hims & Hers to halt sales of a compounded version of its weight-loss drug. The development underscores the pricing power and legal defensibility of branded obesity treatments, a critical theme as competition intensifies in the fast-growing GLP-1 market.
$HIMS Hims & Hers tumbles sharply as it exits the compounded weight-loss segment under mounting legal and regulatory scrutiny. The retreat removes a key growth lever and raises broader questions about the scalability of its model in regulated pharmaceutical categories.
$KR Kroger jumps on reports of a potential CEO appointment with deep Walmart experience. Leadership change in a margin-sensitive retail environment is being viewed as a strategic reset, particularly as grocers navigate inflation dynamics and competitive pricing pressure.
$STM STMicroelectronics surges after securing a multiyear, multibillion-dollar agreement with Amazon Web Services to supply chips and AI-related data center infrastructure. The added equity option strengthens the strategic tie-up and highlights how hyperscalers are locking in semiconductor supply to support long-term AI demand.
$MU Micron declines on reports that Samsung is preparing mass production of next-generation HBM memory. As high-bandwidth memory is central to AI workloads, rising competitive pressure could weigh on pricing power and reshape the competitive landscape in advanced memory.
$AMZN Amazon edges lower following its plan to invest roughly $200 billion in capital expenditures in 2026, largely to meet AI-driven demand. While strategically aligned with long-term growth, the magnitude of spending introduces near-term margin sensitivity, forcing investors to balance scale advantages against capital intensity.
$DT Dynatrace advances after posting strong fiscal third-quarter results and raising its 2026 earnings outlook. The guidance upgrade reinforces confidence in enterprise demand for cloud monitoring and observability tools, particularly as AI-driven workloads add complexity to IT environments.
$CLF Cleveland-Cliffs falls after missing fourth-quarter revenue expectations, underscoring the cyclical vulnerability of steel producers to demand fluctuations and pricing volatility. In a market increasingly driven by structural growth themes like AI and biotech, traditional industrial names remain tightly linked to macro conditions.
Yesterday at 08:37
Yesterday at 08:15
February 7, 2026 08:45 PM
February 6, 2026 11:42 AM
February 6, 2026 08:35 AM
February 6, 2026 04:36 AM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.